Camptothecin compounds having a --CH.sub.2 --L group areeffective anti-tumor compounds. These compounds inhibit the enzymetopoisomerase I and DNA of associated topoisomerase I-DNAcomplexes.
Camptothecin compounds with combined topoisomarase I inhibition and DNA alkylation properties
Wall, M., & Wani, M. (1999). IPC No. U.S. Camptothecin compounds with combined topoisomarase I inhibition and DNA alkylation properties. (U.S. Patent No. 5985888). http://patft.uspto.gov/netacgi/nph-Parser?patentnumber=5985888
Abstract
Abstract
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.